A 58-year-old man with COPD and on long-term oxygen therapy presents with acute worsening of dyspnea, productive cough with greenish sputum, and low-grade fever for 3 days. Chest X-ray shows new infiltrates in the right lower lobe. Sputum culture grows a gram-negative rod that is oxidase-positive, non-fermenting, and produces a characteristic fruity odor. The organism is resistant to multiple antibiotics including aminoglycosides and fluoroquinolones. Which of the following is the most likely diagnosis and the antibiotic of choice for this infection?

Explanation

## Organism Identification **Key Point:** The combination of oxidase-positive, non-fermenting gram-negative rod with fruity (grape-like) odor is pathognomonic for *Pseudomonas aeruginosa*. ### Diagnostic Features of *P. aeruginosa* | Feature | Finding | |---------|----------| | Gram stain | Gram-negative rod | | Oxidase test | **Positive** (key discriminator) | | Fermentation | Non-fermenting (oxidative metabolism) | | Pigment | Pyoverdin (green) + pyocyanin (blue) | | Odor | Fruity/grape-like (characteristic) | | Growth on MacConkey | Non-lactose fermenting, colorless | **High-Yield:** *P. aeruginosa* is an aerobic, non-fermenting gram-negative rod — the oxidase test is the single most important differentiator from *Enterobacteriaceae*. ## Clinical Context This patient has **ventilator-associated pneumonia (VAP) risk** (chronic lung disease, long-term oxygen) with *P. aeruginosa* as the causative agent — a common nosocomial pathogen in respiratory infections. ## Antibiotic Management **Clinical Pearl:** The organism is resistant to aminoglycosides and fluoroquinolones (acquired resistance is common in *P. aeruginosa*). The agents of choice are: 1. **Ceftazidime** (3rd-generation cephalosporin with anti-pseudomonal activity) 2. **Piperacillin-tazobactam** (β-lactam/β-lactamase inhibitor) 3. **Carbapenems** (meropenem, imipenem) — reserved for severe or resistant strains 4. **Fluoroquinolones** (ciprofloxacin, levofloxacin) — second-line if susceptible **Mnemonic:** **CAMP** — *Ceftazidime*, *Aminoglycosides*, *Meropenem*, *Piperacillin-tazobactam* are anti-pseudomonal agents (though aminoglycosides are less reliable as monotherapy now). **Warning:** Do NOT use first- or second-generation cephalosporins — *P. aeruginosa* is intrinsically resistant due to low-affinity penicillin-binding proteins and efflux pumps. ## Why This Patient Has *P. aeruginosa* - **Risk factors:** COPD, chronic hypoxemia, long-term oxygen therapy, potential prior antibiotic exposure - **Habitat:** Ubiquitous in moist environments (water, soil); colonizes respiratory tract in immunocompromised/structurally damaged lungs - **Virulence:** Produces exotoxins (exotoxin A), elastase, and biofilms → difficult to eradicate [cite:Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases Ch 212]